세계의 체외 독성 검사 시장(2023-2030년)

Title: Global In-vitro toxicology testing Market Size, Share & Trends Analysis Report, by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS), by Method (Cellular Assay, Biochemical Assay, In Silica, Ex Vivo), by Application (Systematic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications), by End-User (Pharmaceutical and Biotechnology, Diagnostics, Other End-Users)Forecast Period (2023-2030).

The global in-vitro toxicology testing market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the in-vitro toxicology testing. Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for in-vitro toxicology testing. A significant increase in preclinical pipeline capacity along with growing awareness about the benefits of in-vitro testing services is driving the global market growth. In addition, the traditional rising cost of animal tests as well as their socio-ethical problems is further contributing to the market growth. Significant developments in the in-vitro testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues are some other contributors to the market growth.

To meet the growing demand key players are opening or investing new facilities. For instance, in April 2023, Roquette, a provider of pharmaceutical and nutraceutical excipients, opened its new pharmaceutical innovation center near Philadelphia. The new $25 million center will be an advanced training and collaboration hub for pharmaceutical and nutraceutical manufacturers across the globe. With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette's existing pharma innovation centers in France and Singapore. Underpinning these training sessions and the center's primary research projects is a suite of the latest pharmaceutical processing, testing, and manufacturing equipment.

In the same month, Millipore Sigma has invested $37.5 million to strengthen biosafety testing in Scotland. The investment includes a new 1200-m2 facility in Glasgow that will house molecular biology and sequencing services, and the company will add biosafety testing, analytical development, and viral clearance suites in its current buildings to expand testing capacity.

Segmental Outlook

The global in-vitro toxicology testing market is segmented based on technology, method, application, and end-user. Based on technology, the market is segmented into in cell culture, high throughput, molecular imaging, and OMICS. Based on method, the market is sub-segmented into cellular assay, biochemical assay, in silica, and ex vivo. Based on application, the market is sub-segmented into systematic toxicology, dermal toxicity, endocrine disruption, ocular toxicity, and other applications. Based on end-user, the market is sub-segmented into pharmaceutical and biotechnology, diagnostics, and other end-users.

Cell Culture Holds a Prominent Market Share in the Global In-vitro toxicology testing Market

The cell culture technology segment held considerable share in 2022. The cell cultures provide reproducible results to consistent samples, and serve as excellent models for toxicology assays. Hence, it is highly adopted to perform toxicology testing. This technology further enables early stage drug toxicity testing due to which this technology is gaining popularity & extensive application across the globe.

Regional Outlook

The global in-vitro toxicology testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit highest CAGR in the global in-vitro toxicology testing market. The rising investment by companies from emerging economies in enhancing regional healthcare is a key promoter to the regional market growth. Establishment of new healthcare facilities along with alliances formation with major laboratories is further contributing to the market growth.

North America held Considerable Share in the Global In-Vitro Toxicology Testing Market

North America held considerable share in in-vitro toxicology testing market in 2022. The regional market is driven by the presence of key in-vitro toxicology testing service providers. The rising investments in R&D for the development of novel therapeutics for chronic diseases are further contributing to the market growth. According to EFPIA member associations in 2020, the US has invested $72,412 million in pharmaceutical R&D. Besides, the region has a relatively high disposable income, which enables people to afford expensive drugs and medical treatments. This creates a strong demand for pharmaceutical products in the region; which is further contributing to the regional market growth.

Market Players Outlook

The major companies serving the global in-vitro toxicology testing market include: Abbott Laboratories, Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., and Eurofins Scientific SE among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global in-vitro toxicology testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott Laboratories
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Bio-Rad Laboratories
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Agilent Technologies Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global In-vitro Toxicology Testing Market by Technology
  • 4.1.1. Cell Culture
  • 4.1.2. High Throughput
  • 4.1.3. Molecular Imaging
  • 4.1.4. OMICS
• 4.2. Global In-vitro Toxicology Testing Markey by Method
  • 4.2.1. Cellular Assay
  • 4.2.2. Biochemical Assay
  • 4.2.3. In Silica
  • 4.2.4. Ex Vivo
• 4.3. Global In-vitro Toxicology Testing Market by Application
  • 4.3.1. Systematic Toxicology
  • 4.3.2. Dermal Toxicity
  • 4.3.3. Endorine Disruption
  • 4.3.4. Occular Toxicity
  • 4.3.5. Other Applications
• 4.4. Global In-vitro Toxicology Testing Market by End-User
  • 4.4.1. Pharmaceutical and Biotechnology
  • 4.4.2. Diagnostics
  • 4.4.3. Other End-Users

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Abbott Laboratories
• 6.2. Agilent Technolgies, Inc.
• 6.3. BioIVT
• 6.4. Bio-Rad Laboratories, Inc.
• 6.5. Catalent, Inc.
• 6.6. Charles River Laboratories International, Inc.
• 6.7. Danaher Corp.
• 6.8. Eurofins Scientific
• 6.9. Evotec S.E.
• 6.10. Gentronix
• 6.11. Laboratory Corporation of America Holdings
• 6.12. Merck KGaA
• 6.13. Quest Diagnostics Inc.
• 6.14. SGS S.A.
• 6.15. Thermo Fisher Scientific, Inc.